AI assistant
Sending…
AEHR TEST SYSTEMS — Director's Dealing 2010
Apr 29, 2010
32300_dirs_2010-04-29_26265a11-2306-48bc-b161-c133ecaffd46.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AEHR TEST SYSTEMS (AEHR)
CIK: 0001040470
Period of Report: 2010-04-27
Reporting Person: BUCK CARL N (VP, MARKETING AND CONTACTOR BU)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-04-27 | Common Stock | M | 307 | $2.88 | Acquired | 39924 | Direct |
| 2010-04-27 | Common Stock | M | 1693 | $2.88 | Acquired | 41617 | Direct |
| 2010-04-27 | Common Stock | S | 307 | $3.28 | Disposed | 41310 | Direct |
| 2010-04-27 | Common Stock | S | 1693 | $3.19 | Disposed | 39617 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-04-27 | Incentive Stock Option (right to buy) | $2.88 | M | 307 | Disposed | 2010-06-26 | Common Stock (307) | Direct |
| 2010-04-27 | Incentive Stock Option (right to buy) | $2.88 | M | 1693 | Disposed | 2010-06-26 | Common Stock (1693) | Direct |
Footnotes
F1: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.
F2: Includes (a) 3,000 shares acquired under the Aehr Test Employee Stock Purchase Plan (the "ESPP") on April 1, 2009 (b) 3,000 shares acquired under the ESPP on October 1, 2009 and (c) 3,000 shares acquired under the ESPP on April 1, 2010.
More from AEHR TEST SYSTEMS
Capital/Financing Update
2026
Apr 20
Capital/Financing Update
2026
Apr 8
Earnings Release
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Feb 4